Roivant Sciences (ROIV) Interest Expenses (2022 - 2024)
Roivant Sciences (ROIV) reported Interest Expenses of $13.4 million for Q2 2024, up 50.35% on a YoY basis from $8.9 million in Q3 2023, and up 41.88% quarter-over-quarter from $9.4 million in Q4 2023.
Roivant Sciences (ROIV) Interest Expenses (2022 - 2024) Analysis & Trends
Roivant Sciences has reported Interest Expenses for 3 years, with the latest figure at $13.4 million in Q2 2024.
- For the quarter ending Q2 2024, Interest Expenses rose 50.35% year-over-year to $13.4 million; the trailing twelve-month figure through Mar 2025 stood at $13.4 million (down 51.46% YoY), and the FY2024 full-year result was $34.8 million, up 24.35% from the prior year.
- Interest Expenses for Q2 2024 stood at $13.4 million, up from $9.4 million in the prior quarter.
- The five-year high for Interest Expenses was $13.4 million in Q2 2024, with the low at $2.6 million in Q2 2022.
- Historically, Interest Expenses has averaged $8.6 million across 3 years, with a median of $8.9 million in 2023.
- The largest YoY upside for Interest Expenses was 241.19% in 2023 against a maximum downside of 10.94% in 2023.
- Roivant Sciences' Interest Expenses stood at $8.4 million in 2022, then gained by 11.82% to $9.4 million in 2023, then soared by 41.88% to $13.4 million in 2024.
- The last three Interest Expenses figures came in at $13.4 million (Q2 2024), $9.4 million (Q4 2023), and $9.2 million (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 13.40 Mn |
| Jun 30, 2024 | 13.40 Mn |
| Dec 31, 2023 | 9.44 Mn |
| Dec 31, 2023 | 9.44 Mn |
| Sep 30, 2023 | 9.25 Mn |
| Sep 30, 2023 | 9.25 Mn |
| Jun 30, 2023 | 8.91 Mn |
| Jun 30, 2023 | 8.91 Mn |
| Dec 31, 2022 | 8.45 Mn |
| Dec 31, 2022 | 8.45 Mn |
| Sep 30, 2022 | 8.34 Mn |
| Sep 30, 2022 | 8.34 Mn |
| Jun 30, 2022 | 2.61 Mn |
| Jun 30, 2022 | 2.61 Mn |